SandboxAQ & Deloitte Boost Drug Discovery, OpenAI's AI Access Proposal, and AI Wearables Revolutionize Healthcare - Life AI Weekly #4

Hi there,

In this week's edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. SandboxAQ and Deloitte have expanded their AI partnership to enhance drug discovery processes, while Capgemini is leveraging generative AI for protein engineering. Meanwhile, JelloX Biotech has launched an AI-driven 3D pathology platform aimed at improving oncology outcomes.

On the research front, the National Eye Institute is funding AI research on uveitis, and King's College London has received support for an AI project focused on epilepsy. Additionally, Microsoft and several universities have introduced LLaVA-Rad, a new tool for radiology, and the Mayo Clinic has unveiled OmicsFootPrint, an AI tool designed to visualize complex biological data. Stay tuned for more insights into how AI is transforming the healthcare landscape.

Coeptis Pharmaceuticals, located in Wexford, Pennsylvania, has completed a $10 million Series A Preferred financing round to advance AI-driven technologies and improve operations in the biopharmaceutical field. Avelios, a startup from Munich, has secured $31 million in Series A funding led by Sequoia to create a modern healthcare operating system aimed at replacing outdated hospital IT systems. OpenAI CEO Sam Altman has proposed a 'compute budget' to ensure equitable access to AI technology, addressing concerns about uneven distribution of AI benefits.

SandboxAQ has expanded its alliance with Deloitte to enhance AI simulation software solutions, focusing on Large Quantitative Models (LQMs) to accelerate drug discovery in the biopharma sector. Capgemini has launched a generative AI methodology that significantly reduces data needs in protein engineering, aiming to enhance the bioeconomy across various sectors. Mistral, a French AI startup, plans to invest billions in its first data centre in France to enhance data storage and processing capabilities. JelloX Biotech Inc., a Taiwan-based startup, has announced its new AI-powered 3D digital pathology initiative aimed at enhancing patient care in oncology.

The National Eye Institute has awarded $423,500 to Dr. Siamak Yousefi for AI research to enhance uveitis diagnosis and treatment. Researchers at King's College London have been granted a 16-month funding extension to further their AI project, which focuses on identifying risk factors for drug-resistant epilepsy using electronic health records. A study in Radiology reveals that an AI algorithm can accurately flag women who may benefit from supplemental MRI screenings based on mammogram results, potentially improving breast cancer detection. Researchers from UC San Diego and Linnaeus Bioscience have developed an AI tool that accelerates tuberculosis drug discovery by analyzing cell images, addressing the need for new treatments against drug-resistant strains. Researchers from Microsoft and universities have introduced LLaVA-Rad, a compact model aimed at improving the generation of clinical radiology reports. Researchers at Mayo Clinic have developed an AI tool called OmicsFootPrint that converts complex biological data into visual images, aiding in disease pattern recognition and personalized therapy guidance.

Andor Health has partnered with Vizient to implement its AI virtual care platform, ThinkAndor®. Onc.AI received FDA breakthrough status for its AI model assessing lung cancer mortality risk. Sibel Health's AI wearable reduces dermatitis scratching by 40%, partnering with Maruho for commercialization.